Page last updated: 2024-09-04

docetaxel anhydrous and Aortitis

docetaxel anhydrous has been researched along with Aortitis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Gabata, T; Kozaka, K; Sai, Y; Takamatsu, A; Toshima, F; Yamamoto, N; Yoshida, K	1
Hoshina, H; Takei, H	1
Guido, MC; Kalil-Filho, R; Maranhão, RC; Meneghini, BC; Stefani, HA; Tavares, ER; Tavoni, TM	1

Reviews

1 review(s) available for docetaxel anhydrous and Aortitis

Article	Year
Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer: a case report and review of the literature. BMC cancer, 2019, Dec-16, Volume: 19, Issue:1 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aortitis; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Female; Fever; Filgrastim; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Polyethylene Glycols; Positron Emission Tomography Computed Tomography; Trastuzumab	2019

Article

Year

Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer: a case report and review of the literature.

BMC cancer, 2019, Dec-16, Volume: 19, Issue:1

Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aortitis; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Female; Fever; Filgrastim; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Polyethylene Glycols; Positron Emission Tomography Computed Tomography; Trastuzumab

2019

Other Studies

2 other study(ies) available for docetaxel anhydrous and Aortitis

Article	Year
Single-Center Analysis of Pegfilgrastim-induced Aortitis Using a Drug Prescription Database and CT Findings. Radiology, 2022, Volume: 305, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aortitis; Breast Neoplasms; Cisplatin; Docetaxel; Drug Prescriptions; Esophageal Neoplasms; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Polyethylene Glycols; Retrospective Studies; Tomography, X-Ray Computed	2022
Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Vascular pharmacology, 2019, Volume: 115 Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortitis; Apoptosis Regulatory Proteins; Atherosclerosis; Cell Death; Cell Proliferation; Cholesterol, Dietary; Diet, High-Fat; Disease Models, Animal; Docetaxel; Drug Compounding; Fibrillar Collagens; Inflammation Mediators; Lipids; Male; Nanoparticles; Plaque, Atherosclerotic; Proliferating Cell Nuclear Antigen; von Willebrand Factor	2019

Article

Year

Single-Center Analysis of Pegfilgrastim-induced Aortitis Using a Drug Prescription Database and CT Findings.

Radiology, 2022, Volume: 305, Issue:3

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aortitis; Breast Neoplasms; Cisplatin; Docetaxel; Drug Prescriptions; Esophageal Neoplasms; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Polyethylene Glycols; Retrospective Studies; Tomography, X-Ray Computed

2022

Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model.

Vascular pharmacology, 2019, Volume: 115

Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortitis; Apoptosis Regulatory Proteins; Atherosclerosis; Cell Death; Cell Proliferation; Cholesterol, Dietary; Diet, High-Fat; Disease Models, Animal; Docetaxel; Drug Compounding; Fibrillar Collagens; Inflammation Mediators; Lipids; Male; Nanoparticles; Plaque, Atherosclerotic; Proliferating Cell Nuclear Antigen; von Willebrand Factor

2019